Korro Bio, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Korro Bio, Inc. (KRRO) had Deferred Tax Assets, Operating Loss Carryforwards of $124.62 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-12
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $124.62M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $94.20M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $80.39M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $19.58M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $45.51M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $124.62M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $94.20M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $80.39M 10-K · filed 2025-03-18 | |
| 2022-12-31 | $19.58M 10-K · filed 2024-03-26 | $45.51M 10-K · filed 2023-03-10 |
| 2021-12-31 | $36.59M 10-K · filed 2023-03-10 | |
| 2020-12-31 | $17.89M 10-K · filed 2022-03-15 | |
| 2019-12-31 | $13.25M 10-K · filed 2021-03-29 | |
| 2018-12-31 | $10.71M 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |